|
1
|
Robinson TE and Kolb B: Structural
plasticity associated with exposure to drugs of abuse.
Neuropharmacology. 47(Suppl 1): 33–46. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moeller FG, Barratt ES, Dougherty DM,
Schmitz JM and Swann AC: Psychiatric aspects of impulsivity. Am J
Psychiatry. 158:1783–1793. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lachman HM, Morrow B, Shprintzen R, Veit
S, Parsia SS, Faedda G, et al: Association of codon 108/158
catechol-O-methyltransferase gene polymorphism with the psychiatric
manifestations of velo-cardio-facial syndrome. Am J Med Genet.
67:468–472. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
O'Sullivan SS, Evans AH and Lees AJ:
Dopamine dysregulation syndrome: an overview of its epidemiology,
mechanisms and management. CNS Drugs. 23:157–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weinshilboum RM, Otterness DM and
Szumlanski CL: Methylation pharmacogenetics: catechol
O-methyltransferase, thiopurine methyltransferase, and histamine
N-methyltransferase. Annu Rev Pharmacol Toxicol. 39:19–52. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bruder GE, Keilp JG, Xu H, Shikhman M,
Schori E, Gorman JM, et al: Catechol-O-methyltransferase (COMT)
genotypes and working memory: associations with differing cognitive
operations. Biol Psychiatry. 58:901–907. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malhotra AK, Kestler LJ, Mazzanti C, Bates
JA, Goldberg T and Goldman D: A functional polymorphism in the COMT
gene and performance on a test of prefrontal cognition. Am J
Psychiatry. 159:652–654. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X, Wang X, O'Neill AF, Walsh D and
Kendler KS: Variants in the catechol-o-methyltransferase (COMT)
gene are associated with schizophrenia in Irish high-density
families. Mol Psychiatry. 9:962–967. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Swann AC, Anderson JC, Dougherty DM and
Moeller FG: Measurement of inter-episode impulsivity in bipolar
disorder. Psychiatry Res. 25:195–197. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Winstanley CA, Eagle DM and Robbins TW:
Behavioral models of impulsivity in relation to ADHD: translation
between clinical and preclinical studies. Clin Psychol Rev.
26:379–395. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Egan MF, Goldberg TE, Kolachana BS,
Callicott JH, Mazzanti CM, Straub RE, et al: Effect of COMT
Val108/158 Met genotype on frontal lobe function and risk for
schizophrenia. Proc Natl Acad Sci USA. 98:6917–6722. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nolan KA, D'Angelo D and Hoptman MJ:
Self-report and laboratory measures of impulsivity in patients with
schizophrenia or schizoaffective disorder and healthy controls.
Psychiatry Res. 187:301–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Joober R, Gauthier J, Lal S, Bloom D,
Lalonde P, Rouleau G, et al: Catechol-O-methyltransferase
Val-108/158-Met gene variants associated with performance on the
Wisconsin Card Sorting Test. Arch Gen Psychiatry. 59:662–663. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bilder RM, Volavka J, Lachman HM and Grace
AA: The catechol-O-methyltransferase polymorphism: relations to the
tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.
Neuropsychopharmacology. 29:1943–1961. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Diamond A, Briand L, Fossella J and
Gehlbach L: Genetic and neurochemical modulation of prefrontal
cognitive functions in children. Am J Psychiatry. 161:125–132.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim S and Lee D: Prefrontal cortex and
impulsive decision making. Biol Psychiatry. 69:1140–1146. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jentsch JD and Taylor JR: Impulsivity
resulting from frontostriatal dysfunction in drug abuse:
implications for the control of behavior by reward-related stimuli.
Psychopharmacology (Berl). 146:373–390. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kimberg DY, D'Esposito M and Farah MJ:
Effects of bromocriptine on human subjects depend on working memory
capacity. Neuroreport. 8:3581–3585. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Paloyelis Y, Asherson P, Mehta MA, Faraone
SV and Kuntsi J: DAT1 and COMT effects on delay discounting and
trait impulsivity in male adolescents with attention
deficit/hyperactivity disorder and healthy controls.
Neuropsychopharmacology. 35:2414–2426. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Forbes EE, Brown SM, Kimak M, Ferrell RE,
Manuck SB and Hariri AR: Genetic variation in components of
dopamine neurotransmission impacts ventral striatal reactivity
associated with impulsivity. Mol Psychiatry. 14:60–70. 2009.
View Article : Google Scholar
|
|
21
|
Biederman J, Kim JW, Doyle AE, Mick E,
Fagerness J, Smoller JW and Faraone SV: Sexually dimorphic effects
of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations
of ADHD: a preliminary study. Am J Med Genet B Neuropsychiatr
Genet. 147B:1511–1518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mehta MA, Owen AM, Sahakian BJ, Mavaddat
N, Pickard JD and Robbins TW: Methylphenidate enhances working
memory by modulating discrete frontal and parietal lobe regions in
the human brain. J Neurosci. 20:RC652000.PubMed/NCBI
|
|
23
|
Colzato LS, van den Wildenberg WP, Van der
Does AJ and Hommel B: Genetic markers of striatal dopamine predict
individual differences in dysfunctional, but not functional
impulsivity. Neuroscience. 170:782–788. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goldman-Rakic PS, Castner SA, Svensson TH,
Siever LJ and Williams GV: Targeting the dopamine D1 receptor in
schizophrenia: insights for cognitive dysfunction.
Psychopharmacology (Berl). 174:3–16. 2004.PubMed/NCBI
|
|
25
|
Dalley JW, Fryer TD, Brichard L, Robinson
ES, Theobald DE, Lääne K, et al: Nucleus accumbens D2/3 receptors
predict trait impulsivity and cocaine reinforcement. Science.
315:1267–1270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Patton JH, Stanford MS and Barratt ES:
Factor structure of the Barratt impulsiveness scale. J Clin
Psychol. 51:768–774. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cools R, Barker RA, Sahakian BJ and
Robbins TW: L-Dopa medication remediates cognitive inflexibility,
but increases impulsivity in patients with Parkinson's disease.
Neuropsychologia. 41:1431–1441. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gogos JA, Morgan M, Luine V, Santha M,
Ogawa S, Pfaff D and Karayiorgou M:
Catechol-O-methyltransferase-deficient mice exhibit sexually
dimorphic changes in catecholamine levels and behavior. Proc Natl
Acad Sci USA. 95:9991–9996. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sheehan DV, Lecrubier Y, Sheehan KH,
Amorim P, Janavs J, Weiller E, et al: The Mini-International
Neuropsychiatric Interview (M.I.N.I.): the development and
validation of a structured diagnostic psychiatric interview for
DSM-IV and ICD-10. J Clin Psychiatry. 59(Suppl 20): 22–33; quiz
34–57. 1998.PubMed/NCBI
|
|
30
|
Robert G, Drapier D, Verin M, Millet B,
Azulay JP and Blin O: Cognitive impulsivity in Parkinson's disease
patients: assessment and pathophysiology. Mov Disord. 24:2316–2327.
2009.
|
|
31
|
Dang D, Cunnington D and Swieca J: The
emergence of devastating impulse control disorders during dopamine
agonist therapy of the restless legs syndrome. Clin Neuropharmacol.
34:66–70. 2011.PubMed/NCBI
|
|
32
|
Lachman HM, Papolos DF, Saito T, Yu YM,
Szumlanski CL and Weinshilboum RM: Human
catechol-O-methyltransferase pharmacogenetics: description of a
functional polymorphism and its potential application to
neuropsychiatric disorders. Pharmacogenetics. 6:243–250. 1996.
View Article : Google Scholar
|
|
33
|
Laitinen J, Samarut J and Hölttä E: A
nontoxic and versatile protein salting-out method for isolation of
DNA. Biotechniques. 17:316318320–322. 1994.PubMed/NCBI
|
|
34
|
Swann AC, Bjork JM, Moeller FG and
Dougherty DM: Two models of impulsivity: relationship to
personality traits and psychopathology. Biol Psychiatry.
51:988–994. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hinson JM, Jameson TL and Whitney P:
Impulsive decision making and working memory. J Exp Psychol Learn
Mem Cogn. 29:298–306. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Green L, Myerson J and Ostaszewski P:
Amount of reward has opposite effects on the discounting of delayed
and probabilistic outcomes. J Exp Psychol Learn Mem Cogn.
25:418–427. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Richards JB, Zhang L, Mitchell SH and de
Wit H: Delay or probability discounting in a model of impulsive
behavior: effect of alcohol. J Exp Anal Behav. 71:121–143. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
DeYoung CG, Getchell M, Koposov RA,
Yrigollen CM, Haeffel GJ, af Klinteberg B, et al: Variation in the
catechol-O-methyltransferase Val 158 Met polymorphism associated
with conduct disorder and ADHD symptoms, among adolescent male
delinquents. Psychiatr Genet. 20:20–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Boettiger CA, Mitchell JM, Tavares VC,
Robertson M, Joslyn G, D'Esposito M and Fields HL: Immediate reward
bias in humans: fronto-parietal networks and a role for the
catechol-O-methyltransferase 158(Val/Val) genotype. J Neurosci.
27:14383–14391. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Stanford MS, Mathias CW, Dougherty DM,
Lake SL, Anderson NE and Patton JH: Fifty years of the Barratt
Impulsiveness Scale: An update and review. Personality and
Individual Differences. 47:385–395. 2009.
|
|
41
|
Whitney P, Jameson T and Hinson JM:
Impulsiveness and executive control of working memory. Pers Individ
Diff. 37:417–428. 2004. View Article : Google Scholar
|
|
42
|
St Onge JR and Floresco SB: Dopaminergic
modulation of risk-based decision making. Neuropsychopharmacology.
34:681–697. 2009.PubMed/NCBI
|
|
43
|
Comings DE, Gade R, Wu S, Chiu C, Dietz G,
Muhleman D, et al: Studies of the potential role of the dopamine D1
receptor gene in addictive behaviors. Mol Psychiatry. 2:44–56.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Buckholtz JW, Treadway MT, Cowan RL,
Woodward ND, Li R, Ansari MS, et al: Dopaminergic network
differences in human impulsivity. Science. 329:5322010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Han DH, Park DB, Na C, Kee BS and Lee YS:
Association of aggressive behavior in Korean male schizophrenic
patients with polymorphisms in the serotonin transporter promoter
and catecholamine-O-methyltransferase genes. Psychiatry Res.
129:29–37. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Han DH, Kee BS, Min KJ, Lee YS, Na C, Park
DB and Lyoo IK: Effects of catechol-O-methyltransferase Val158Met
polymorphism on the cognitive stability and aggression in the
first-onset schizophrenic patients. Neuroreport. 17:95–99. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nedic G, Nikolac M, Sviglin KN, Muck-Seler
D, Borovecki F and Pivac N: Association study of a functional
catechol-O-methyltransferase (COMT) Val108/158Met polymorphism and
suicide attempts in patients with alcohol dependence. Int J
Neuropsychopharmacol. 14:377–388. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Goldberg TE, Egan MF, Gscheidle T, Coppola
R, Weickert T, Kolachana BS, et al: Executive subprocesses in
working memory: relationship to catechol-O-methyltransferase
Val158Met genotype and schizophrenia. Arch Gen Psychiatry.
60:889–896. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Williams-Gray CH, Hampshire A, Robbins TW,
Owen AM and Barker RA: Catechol O-methyltransferase Val158Met
genotype influences frontoparietal activity during planning in
patients with Parkinson's disease. J Neurosci. 27:4832–4838. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Soeiro-de-Souza MG, Bio DS, David DP,
Rodrigues dos Santos D Jr, Kerr DS, Gattaz WF, Machado-Vieira R and
Moreno RA: COMT Met (158) modulates facial emotion recognition in
bipolar I disorder mood episodes. J Affect Disord. 136:370–376.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Soeiro-de-Souza MG, Machado-Vieira R,
Soares Bio D, Do Prado CM and Moreno RA: COMT polymorphisms as
predictors of cognitive dysfunction during manic and mixed episodes
in bipolar I disorder. Bipolar Disord. 14:554–564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Baca-García E, Salgado BR, Segal HD,
Lorenzo CV, Acosta MN, Romero MA, et al: A pilot genetic study of
the continuum between compulsivity and impulsivity in females: the
serotonin transporter promoter polymorphism. Prog
Neuropsychopharmacol Biol Psychiatry. 29:713–717. 2005.PubMed/NCBI
|
|
53
|
Sakado K, Sakado M, Muratake T, Mundt C
and Someya T: A psychometrically derived impulsive trait related to
a polymorphism in the serotonin transporter gene-linked polymorphic
region (5-HTTLPR) in a Japanese nonclinical population: assessment
by the Barratt impulsiveness scale (BIS). Am J Med Genet B
Neuropsychiatr Genet. 121B:71–75. 2003. View Article : Google Scholar
|
|
54
|
Lopez de Lara C, Brezo J, Rouleau G,
Lesage A, Dumont M, Alda M, et al: Effect of tryptophan
hydroxylase-2 gene variants on suicide risk in major depression.
Biol Psychiatry. 62:72–80. 2007.PubMed/NCBI
|
|
55
|
Bjork JM, Moeller FG, Dougherty DM, Swann
AC, Machado MA and Hanis CL: Serotonin 2a receptor T102C
polymorphism and impaired impulse control. Am J Med Genet.
114:336–339. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zouk H, McGirr A, Lebel V, Benkelfat C,
Rouleau G and Turecki G: The effect of genetic variation of the
serotonin 1B receptor gene on impulsive aggressive behavior and
suicide. Am J Med Genet B Neuropsychiatr Genet. 144B:996–1002.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Paaver M, Nordquist N, Parik J, Harro M,
Oreland L and Harro J: Platelet MAO activity and the 5-HTT gene
promoter polymorphism are associated with impulsivity and cognitive
style in visual information processing. Psychopharmacology (Berl).
194:545–554. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Passamonti L, Fera F, Magariello A, Cerasa
A, Gioia MC, Muglia M, et al: Monoamine oxidase-a genetic
variations influence brain activity associated with inhibitory
control: new insight into the neural correlates of impulsivity.
Biol Psychiatry. 59:334–340. 2006. View Article : Google Scholar
|
|
59
|
Alsene K, Deckert J, Sand P and de Wit H:
Association between A2a receptor gene polymorphisms and
caffeine-induced anxiety. Neuropsychopharmacology. 28:1694–1702.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Sequeira A, Mamdani F, Lalovic A,
Anguelova M, Lesage A, Seguin M, et al: Alpha 2A adrenergic
receptor gene and suicide. Psychiatry Res. 125:87–93. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Evenden JL: Varieties of impulsivity.
Psychopharmacology (Berl). 146:348–361. 1999. View Article : Google Scholar : PubMed/NCBI
|
